TD Cowen analyst Bryan Bergin lowered the firm’s price target on Cognizant (CTSH) to $85 from $86 and keeps a Hold rating on the shares. The firm said they posted a fine quarter, led by BFS, bookings and SG&A cost control. FY26 guide landed lighter versus buyside view, though better demand backdrop exists, including discretionary thawing (BFSI-led) that implies guide conservatism.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTSH:
- Cognizant price target raised to $82 from $80 at Morgan Stanley
- Cognizant: Solid Execution, Strong Bookings, and Strategic AI Positioning Underpin Buy Rating
- Cognizant Earnings Call Highlights Profitable, AI‑Driven Growth
- Cognizant data points suggest gaining traction in AI, says Evercore ISI
- Morning Movers: Eli Lilly rises, Boston Scientific falls after quarterly results